FDA to Host Meeting on Public Availability of Clinical Trial Information

Summary

The Food and Drug Administration (FDA) is hosting a meeting to discuss the public availability of information on clinical trials for investigational devices intended to treat serious or life-threatening conditions, as required by the FDA Modernization Act of 1997 (FDAMA). The meeting aims to assist the agency in preparing a report to Congress.